Skip to main content
AVAH logo

AVAH · Aveanna Healthcare Holdings, Inc. · Metrics

Track AVAH — free
$12.41 -0.37 (-2.90%) At close · Sep 30
Market Cap
$2.75B
Shares
218.22M
Volume · Sep 30 5.8M Avg daily vol (3M) 2.99M

AVAH metrics

84 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$12.41
Market cap
$2.75B

Price action

20 metrics
Price change (1W)
-3.3%
Price change (30D)
-4.8%
Price change (3M)
+49.1%
Price change (6M)
+98.4%
Price change (YTD)
+56.4%
Price change (1Y)
+44.1%
Trailing year
Price change (5Y)
+62.4%
52-week high
$14.38
52-week low
$6.22
Change from 52-week high
-11.1%
Change from 52-week low
+105.5%
Annualized volatility
50.3%
Annualized volatility (3M)
63.0%
Beta
0.7
RSI (14D)
47.3
Price vs SMA 50
+6.5%
Price vs SMA 200
+45.6%
Avg volume (3M)
2.93M
Relative volume
0.7
Average dollar volume
$34.92M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
218.22M

Valuation

12 metrics
P / E (TTM)
10.1
Trailing earnings · reciprocal yield 9.9%
PEG ratio
0.3
EV / revenue
1.5×
reciprocal yield 65.9%
EV / EBITDA
13.8×
reciprocal yield 7.2%
EV / EBIT
14.4×
reciprocal yield 6.9%
P / sales
1.1×
reciprocal yield 94.7%
P / book
9.6
reciprocal yield 10.5%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
16.3
reciprocal yield 6.1%
Earnings yield
10.0%

Historical valuation

8 metrics
P / E historical average (3Y)
48.7×
reciprocal yield 2.1%
P / E historical average (5Y)
48.7×
reciprocal yield 2.1%
EV / revenue historical average (3Y)
1.1×
reciprocal yield 92.8%
EV / revenue historical average (5Y)
1.0×
reciprocal yield 97.3%
EV / EBIT historical average (3Y)
55.4×
reciprocal yield 1.8%
EV / EBIT historical average (5Y)
55.4×
reciprocal yield 1.8%
EV / EBITDA historical average (3Y)
29.8×
reciprocal yield 3.4%
EV / EBITDA historical average (5Y)
29.8×
reciprocal yield 3.4%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
32.3%
Operating margin
10.5%
Trailing 12 months
Net margin
10.6%
Gross profit (TTM)
$840.08M
Operating profit (TTM)
$273.93M
Net income (TTM)
$274.76M
Trailing 12 months
Diluted EPS (TTM)
$1.26
FCF margin
—
Effective tax rate
-78.3%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.92

Growth

11 metrics
Revenue growth YoY
+13.7%
Year over year
Net income growth YoY
+49.1%
Revenue (TTM)
$2.60B
Trailing 12 months
EPS growth YoY
+38.5%
Shares change YoY
+6.9%
Year over year · more shares
Revenue CAGR (3Y)
+10.8%
Revenue CAGR (5Y)
+10.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
95.6%
Return on assets
13.0%
Debt / equity
4.5
Current ratio
1.2
EBITDA (TTM)
$285.15M
Free cash flow (TTM)
—
Quick ratio
1.2
Interest coverage
2.2
Net debt / EBITDA
4.2
Return on invested capital
—
Trailing 12 months
Net cash
−$1.20B
Latest balance sheet
Cash & equivalents
$97.20M
Total assets
$2.11B
Total debt
$1.30B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$168.20M
Capital expenditures (TTM)
$14.44M
R&D (TTM)
—
SG&A (TTM)
$385.91M
Stock compensation (TTM)
$17.19M
R&D / revenue
—
Stock compensation / revenue
0.7%

Ownership (13F)

3 metrics
13F filers
216
13F filer change QoQ
+17
Institutional ownership
92.6%

Short interest

3 metrics
Short interest
2.5%
Latest settlement · 1.9 days to cover
Days to cover
1.9d
Short-squeeze score
54 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$558.51M
Insider-sentiment score
1 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1832332 CUSIP 05356F105 13F (30d) 6 filings 6 filers Visit website Investor relations